chlorpromazine and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide

chlorpromazine has been researched along with n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartenstein, P; Chowdhury, S; Djurova, P; Fricker, G; Höfner, G; Purisima, EO; Schirrmacher, R; Wängler, B; Wängler, C; Wanner, KT	1

Other Studies

1 other study(ies) available for chlorpromazine and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide

Article	Year
Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding? Journal of medicinal chemistry, 2014, May-22, Volume: 57, Issue:10 Topics: Amino Acid Sequence; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Biological Transport; Blood-Brain Barrier; Carrier Proteins; Dopamine Antagonists; Humans; Ligands; Models, Molecular; Molecular Docking Simulation; Molecular Sequence Data; Receptors, Dopamine D2; Receptors, Transferrin; Transcytosis	2014

Article

Year

Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding?

Journal of medicinal chemistry, 2014, May-22, Volume: 57, Issue:10

Topics: Amino Acid Sequence; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Biological Transport; Blood-Brain Barrier; Carrier Proteins; Dopamine Antagonists; Humans; Ligands; Models, Molecular; Molecular Docking Simulation; Molecular Sequence Data; Receptors, Dopamine D2; Receptors, Transferrin; Transcytosis

2014